BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2814484
Number of visits today
588
Number of downloads
2064808
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Li W, Zhang Z, Wang B, Liang N, Zhou Q, Long S. MicroRNA and cyclooxygenase-2 in breast cancer. Clin Chim Acta 2021;522:36-44. [PMID: 34389281 DOI: 10.1016/j.cca.2021.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 El-Mahdy HA, Elsakka EGE, El-Husseiny AA, Ismail A, Yehia AM, Abdelmaksoud NM, Elshimy RAA, Noshy M, Doghish AS. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. Pathol Res Pract 2023;242:154316. [PMID: 36682282 DOI: 10.1016/j.prp.2023.154316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Shaker AM, Shahin MI, Aboulmagd AM, Abdel Aleem SA, Abdel-rahman HM, Abou El Ella DA. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2. Bioorganic Chemistry 2022;129:106143. [DOI: 10.1016/j.bioorg.2022.106143] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zheng L, Wang J, Jiang H, Dong H, Wang F. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/3391878] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 El-Sheikh A, Khired Z. Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity. Medicina (Kaunas) 2021;58:46. [PMID: 35056355 DOI: 10.3390/medicina58010046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345